Search research articles
Contact Us
Filters
Showing results (1-10 of 32) with videos related to
Page
of 4
Sort By:
Current Medicinal Chemistry
|
February 7, 2012
Regulation of glutamate synthesis via inhibition of glutamate carboxypeptidase II (GCPII): an effective method to treat central and peripheral nervous system disorders
Guido Cavaletti, Barbara Slusher
Cerebrum : the Dana Forum on Brain Science
|
March 1, 2013
Cognitive impairment in multiple sclerosis: a forgotten disability remembered
Kristen Rahn, Barbara Slusher, Adam Kaplin
Clinical Advances in Hematology & Oncology : H&O
|
April 20, 2013
Emerging treatments in chemotherapy-induced nausea and vomiting
Steven M Grunberg, Barbara Slusher, Hope S Rugo
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 26, 2013
Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme
Jesse Alt, Marigo Stathis, Camilo Rojas, et al.
Analytical Biochemistry
|
September 6, 2011
Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine
Jesse Alt, Camilo Rojas, Krystyna Wozniak, et al.
Journal of Neurochemistry
|
March 20, 2004
Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3
Alison Berent-Spillson, Amanda M Robinson, David Golovoy, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Single-cell RNA sequencing reveals that host Glutamine Metabolism Inhibition Enhances Macrophage Phagocytosis of <i>Mycobacterium tuberculosis</i>
Yingli Shi, Lesly Rodriguez Vicens, Micheal Teve, et al.
Endocrinology
|
October 27, 2009
Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy
Viktor R Drel, Weizheng Xu, Jie Zhang, et al.
Journal of Neuroscience Research
|
August 19, 2014
Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism
Sofya Abazyan, Eun Ju Yang, Bagrat Abazyan, et al.
International Journal of Molecular Medicine
|
May 28, 2011
Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice
Viktor R Drel, Pal Pacher, Roman Stavniichuk, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 32) with videos related to
Sort By:
Page
of 4
Current Medicinal Chemistry
|
February 7, 2012
Regulation of glutamate synthesis via inhibition of glutamate carboxypeptidase II (GCPII): an effective method to treat central and peripheral nervous system disorders
Guido Cavaletti, Barbara Slusher
Cerebrum : the Dana Forum on Brain Science
|
March 1, 2013
Cognitive impairment in multiple sclerosis: a forgotten disability remembered
Kristen Rahn, Barbara Slusher, Adam Kaplin
Clinical Advances in Hematology & Oncology : H&O
|
April 20, 2013
Emerging treatments in chemotherapy-induced nausea and vomiting
Steven M Grunberg, Barbara Slusher, Hope S Rugo
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
March 26, 2013
Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme
Jesse Alt, Marigo Stathis, Camilo Rojas, et al.
Analytical Biochemistry
|
September 6, 2011
Development of a high-throughput method for the determination of pharmacological levels of plasma D-serine
Jesse Alt, Camilo Rojas, Krystyna Wozniak, et al.
Journal of Neurochemistry
|
March 20, 2004
Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3
Alison Berent-Spillson, Amanda M Robinson, David Golovoy, et al.
Biorxiv : the Preprint Server for Biology
|
May 25, 2026
Single-cell RNA sequencing reveals that host Glutamine Metabolism Inhibition Enhances Macrophage Phagocytosis of <i>Mycobacterium tuberculosis</i>
Yingli Shi, Lesly Rodriguez Vicens, Micheal Teve, et al.
Endocrinology
|
October 27, 2009
Poly(Adenosine 5'-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy
Viktor R Drel, Weizheng Xu, Jie Zhang, et al.
Journal of Neuroscience Research
|
August 19, 2014
Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolism
Sofya Abazyan, Eun Ju Yang, Bagrat Abazyan, et al.
International Journal of Molecular Medicine
|
May 28, 2011
Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice
Viktor R Drel, Pal Pacher, Roman Stavniichuk, et al.
Page
of 4